Details for 2012723023
Up to date per 01.04.2026
Actions
Details for 2012723023
Granted/Registered
European Patent
19.03.2014 A
26.06.2019 B1
10.05.2011
US
201161484222 P
A61K 47/34 20170101AFI20121130BHEP
Owner
Antecip Bioventures II LLC630 Fifth Avenue, Suite 2000 New York, New York 10111US
Representative
Representative
Dipl.-Ing. Werner Barger, Dipl.-Ing. Dr. techn. Peter IsrailoffOperngasse 41010 WienAT
Inventor
TABUTEAU, Herriot260 Park Avenue South, Apt. 7B New York NY 10010US
Information about Fees